Daiichi Sankyo Company, Limited – OTC:DSKYF

Daiichi Sankyo Company, Limited stock price today

$25.91
-0.83
-3.14%
Financial Health
0
1
2
3
4
5
6
7
8
9

Daiichi Sankyo Company, Limited stock price monthly change

-24.82%
month

Daiichi Sankyo Company, Limited stock price quarterly change

-24.82%
quarter

Daiichi Sankyo Company, Limited stock price yearly change

-0.37%
year

Daiichi Sankyo Company, Limited key metrics

Market Cap
59.88B
Enterprise value
7.29T
P/E
35.26
EV/Sales
4.32
EV/EBITDA
23.17
Price/Sales
4.74
Price/Book
4.69
PEG ratio
N/A
EPS
33.46
Revenue
1.27T
EBITDA
54.73B
Income
64.16B
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
13.58%
Oper. margin
12.22%
Gross margin
75.3%
EBIT margin
12.22%
EBITDA margin
4.3%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Daiichi Sankyo Company, Limited stock price history

Daiichi Sankyo Company, Limited stock forecast

Daiichi Sankyo Company, Limited financial statements

Daiichi Sankyo Company, Limited (OTC:DSKYF): Profit margin
Dec 2021 281.00B 31.85B 11.34%
Mar 2022 233.92B -27.34B -11.69%
Mar 2023 330.20B 22.48B 6.81%
Mar 2024 428.41B 37.16B 8.68%
Daiichi Sankyo Company, Limited (OTC:DSKYF): Analyst Estimates
2026 1.88T 237.94B 12.59%
2027 2.20T 337.06B 15.28%
2028 2.65T 495.90B 18.68%
2029 2.94T 536.13B 18.18%
  • Analysts Price target

  • Financials & Ratios estimates

1.51%
Yield TTM
Daiichi Sankyo Company, Limited (OTC:DSKYF): Payout ratio
Payout ratio 41.93%
Daiichi Sankyo Company, Limited (OTC:DSKYF): Dividend Yield
2020 0.95%
2021 0.77%
2022 1.03%
2023 0.58%
2024 0.73%
Daiichi Sankyo Company, Limited (OTC:DSKYF): Debt to assets
Sep 2022 2427775000000 960.62B 39.57%
Dec 2022 2398031000000 983.70B 41.02%
Mar 2023 2508889000000 1.05T 42.13%
Mar 2024 3461135000000 1.76T 50.94%
Daiichi Sankyo Company, Limited (OTC:DSKYF): Cash Flow
Dec 2021 69.67B -16.04B -29.88B
Mar 2022 38.08B 39.81B -3.59B
Mar 2023 32.37B 17.69B -3.79B
Mar 2024 29.96B -63.40B -3.83B

Daiichi Sankyo Company, Limited alternative data

Daiichi Sankyo Company, Limited (OTC:DSKYF): Employee count
Aug 2023 17,435
Sep 2023 17,435
Oct 2023 17,435
Nov 2023 17,435
Dec 2023 17,435
Jan 2024 17,435
Feb 2024 17,435
Mar 2024 17,435
Apr 2024 17,435
May 2024 17,435
Jun 2024 17,435
Jul 2024 18,726

Daiichi Sankyo Company, Limited other data

  • What's the price of Daiichi Sankyo Company, Limited stock today?

    One share of Daiichi Sankyo Company, Limited stock can currently be purchased for approximately $25.91.

  • When is Daiichi Sankyo Company, Limited's next earnings date?

    Daiichi Sankyo Company, Limited is estimated to report earnings on Tuesday, 28 Oct 2025.

  • Does Daiichi Sankyo Company, Limited pay dividends?

    Yes, Daiichi Sankyo Company, Limited pays dividends and its trailing 12-month yield is 1.51% with 42% payout ratio. The last Daiichi Sankyo Company, Limited stock dividend of undefined was paid on 1 Sep 2025.

  • How much money does Daiichi Sankyo Company, Limited make?

    Daiichi Sankyo Company, Limited has a market capitalization of 59.88B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 25.28% to 1.6T US dollars.

  • What is Daiichi Sankyo Company, Limited's stock symbol?

    Daiichi Sankyo Company, Limited is traded on the OTC under the ticker symbol "DSKYF".

  • What is Daiichi Sankyo Company, Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—General industry.

  • How do i buy shares of Daiichi Sankyo Company, Limited?

    Shares of Daiichi Sankyo Company, Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Daiichi Sankyo Company, Limited have?

    As Jul 2024, Daiichi Sankyo Company, Limited employs 18,726 workers, which is 7% more then previous month and 7% more then previous quarter.

  • When Daiichi Sankyo Company, Limited went public?

    Daiichi Sankyo Company, Limited is publicly traded company for more then 17 years since IPO on 24 Jun 2008.

  • What is Daiichi Sankyo Company, Limited's official website?

    The official website for Daiichi Sankyo Company, Limited is daiichisankyo.com.

  • How can i contact Daiichi Sankyo Company, Limited?

    Daiichi Sankyo Company, Limited can be reached via phone at +81 3 6225 1111.

Daiichi Sankyo Company, Limited company profile:

Daiichi Sankyo Company, Limited

daiichisankyo.com
Exchange:

OTC

Full time employees:

16,458

Industry:

Drug Manufacturers—General

Sector:

Healthcare

Daiichi Sankyo Company, Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; and ferric carboxymaltose injection for treating anemia. It also provides edoxaban, an oral, once-daily, direct factor Xa inhibitor; esaxerenone and olmesartan medoxomil antihypertensive agents; NILEMDO, an oral treatment to help in lowering cholesterol; and Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe for reducing cholesterol. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgality for the treatment of migraine attacks; Pralia for the treatment of osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications caused by bone metastases from tumors; Tarlige for treating pain; Tenelia for the treatment of Type 2 diabetes mellitus; Venofer for the treatment of iron deficiency anemia; and Vimpat, an anti-epileptic agent. Further, it provides vaccines for influenza, measles/rubella infection, and mumps. The company was founded in 1899 and is headquartered in Tokyo, Japan.

3-5-1, Nihonbashi-honcho
Tokyo, 103-8426

:
:
: